India drugmaker stocks exception in Asian rout

SINGAPORE/MUMBAI, Sept 3 (Reuters) - The double-digit stock market gains of Indian pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year. Continued strength in the dollar when the Federal Reserve raises interest rates will also boost their income. More than 40 percent of over-the-counter and generic prescription drugs sold in the United States come from India.